WVE SCHEDULE 13D/A: SEC filing
Filed with the SEC on · accession 0001346824-26-000222
WVE filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Aug 11, 2026. RA Capital Management, Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund filed a Joint Filing Agreement as an exhibit to an amended Schedule 13D regarding their beneficial ownership of Wave Life Sciences common stock. The stock moved -16.6% by the first close after the filing.
Summary of the filing
RA Capital Management, Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund filed a Joint Filing Agreement as an exhibit to an amended Schedule 13D regarding their beneficial ownership of Wave Life Sciences common stock. The agreement allows the filers to submit a single joint Schedule 13G/13D statement.
Key details
How WVE stock reacted
Close before
$6.05
Aug 10, 2026
First close after
-16.61%
$5.04
5 trading days
-15.87%
$5.09
Since filing
-44.38%
$3.37
✦ Ask GOAX AI about this filing — what it means for WVE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for WVE?
Click hereFrequently asked questions
What did WVE file with the SEC on Aug 11, 2026?
WVE filed a SCHEDULE 13D/A (SEC filing). RA Capital Management, Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund filed a Joint Filing Agreement as an exhibit to an amended Schedule 13D regarding their beneficial ownership of Wave Life Sciences common stock. The agreement allows the filers to submit a single joint Schedule 13G/13D statement.
How do I read a SCHEDULE 13D/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).
How did WVE stock react to this filing?
WVE closed at $6.05 before the filing and $5.04 on Aug 11, 2026 (-16.61%). Five trading days later: $5.09 (-15.87%).
Other WVE SEC filings
- SCHEDULE 13G · SEC filingOct 27, 2026
- SCHEDULE 13G/A · SEC filingOct 27, 2026
- 8-K · SEC filingOct 27, 2026
- 10-Q · SEC filingOct 27, 2026
- DEF 14A · Board changeOct 14, 2026
- 8-K · SEC filingJul 30, 2026
- 10-Q · SEC filingJul 30, 2026
- 8-K · SEC filingJun 26, 2026
- 8-K · Fda approvalMay 18, 2026
- DEF 14A · Board changeMay 7, 2026
Get alerts when WVE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days